Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Tampa, Florida Clinical Trials

A listing of Tampa, Florida clinical trials actively recruiting patient volunteers.

RESULTS

Found (4) clinical trials

Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

This is study is a placebo controlled study where subjects with moderate to severe atopic dermatitis will be randomized (1:1:1:1) to receive ASN002 at 40 mg, 60 mg, or 80 mg, or placebo once daily for 12 weeks. Eligible subjects will get the opportunity to enroll in the 24 month ...

Phase

5.47 miles

Learn More »

Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

Vemurafenib and cobimetinib are already U.S. Food and Drug Administration (FDA)-approved for the treatment of BRAF-mutant metastatic melanoma; however, melanoma often develops resistance to these drugs over time, and the tumors start to re-grow. Investigators will use the participant's LDH (lactate dehydrogenase) levels obtained from routine blood work, along with ...

Phase N/A

8.88 miles

Learn More »

Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant

PRIMARY OBJECTIVES: I. Determine whether 2-5 year hematopoietic cell transplant (HCT) survivors with elevated cancer-related distress or poor health care adherence, adherence to cardiometabolic or subsequent malignancy surveillance who are randomized to receive the online, patient-centered, self-management stepped care program will report reduced distress, and improved health care adherence for ...

Phase N/A

8.88 miles

Learn More »

A Study of NKTR-358 in Participants With Systemic Lupus Erythematosis (SLE)

NKTR-358 is a potential first-in-class therapeutic that may address an underlying immune system imbalance in patients with many autoimmune conditions. It targets the interleukin (IL-2) receptor complex in the body in order to stimulate proliferation of inhibitory immune cells known as regulatory T cells. By activating these cells, NKTR-358 may ...

Phase

9.85 miles

Learn More »